 | • レポートコード：GIR-107A12382 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、感染症ポイントオブケア診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。感染症ポイントオブケア診断の種類別市場規模（市販（OTC）検査、処方箋ベース検査キット）、用途別市場規模（細菌感染症、真菌感染症、ウイルス感染症、心血管感染症、胃腸感染症、性感染症（STD）感染症、中枢神経系感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・感染症ポイントオブケア診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Siemens、GE Healthcare、Accriva、Terumo、BioMerieux、Diasorin、Roche、Danaher Corporation、BD、Bio-Rad Laboratories、Cavidi、Cepheid、Diaxonhit、Eiken Chemical、EMD Millipore、Epitope Diagnostic、Euroimmun、Gold Standard Diagnostics、Hologic、Immunetics、InBios International ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：市販（OTC）検査、処方箋ベース検査キット ・用途別分析2016年-2026年：細菌感染症、真菌感染症、ウイルス感染症、心血管感染症、胃腸感染症、性感染症（STD）感染症、中枢神経系感染症、その他 ・感染症ポイントオブケア診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・感染症ポイントオブケア診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・感染症ポイントオブケア診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・感染症ポイントオブケア診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・感染症ポイントオブケア診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Infectious Disease Point of Care Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Infectious Disease Point of Care Diagnostics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Infectious Disease Point of Care Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Infectious Disease Point of Care Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
Market segment by Application, can be divided into
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
Market segment by players, this report covers
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Infectious Disease Point of Care Diagnostics
1.2 Classification of Infectious Disease Point of Care Diagnostics by Type
1.2.1 Overview: Global Infectious Disease Point of Care Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type in 2020
1.2.3 Over-the-counter (OTC) Testing Kits
1.2.4 Prescription-based Testing Kits
1.3 Global Infectious Disease Point of Care Diagnostics Market by Application
1.3.1 Overview: Global Infectious Disease Point of Care Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Bacterial Infections
1.3.3 Fungal Infection
1.3.4 Virus Infection
1.3.5 Cardiovascular Infection
1.3.6 Gastrointestinal Infection
1.3.7 Sexually Transmitted Disease (STD) Infection
1.3.8 Central Nervous System Infection
1.3.9 Other
1.4 Global Infectious Disease Point of Care Diagnostics Market Size & Forecast
1.5 Global Infectious Disease Point of Care Diagnostics Market Size and Forecast by Region
1.5.1 Global Infectious Disease Point of Care Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Infectious Disease Point of Care Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Infectious Disease Point of Care Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Infectious Disease Point of Care Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Infectious Disease Point of Care Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Infectious Disease Point of Care Diagnostics Market Drivers
1.6.2 Infectious Disease Point of Care Diagnostics Market Restraints
1.6.3 Infectious Disease Point of Care Diagnostics Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Infectious Disease Point of Care Diagnostics Product and Solutions
2.1.4 Abbott Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Siemens
2.2.1 Siemens Details
2.2.2 Siemens Major Business
2.2.3 Siemens Infectious Disease Point of Care Diagnostics Product and Solutions
2.2.4 Siemens Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Siemens Recent Developments and Future Plans
2.3 GE Healthcare
2.3.1 GE Healthcare Details
2.3.2 GE Healthcare Major Business
2.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Product and Solutions
2.3.4 GE Healthcare Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GE Healthcare Recent Developments and Future Plans
2.4 Accriva
2.4.1 Accriva Details
2.4.2 Accriva Major Business
2.4.3 Accriva Infectious Disease Point of Care Diagnostics Product and Solutions
2.4.4 Accriva Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Accriva Recent Developments and Future Plans
2.5 Terumo
2.5.1 Terumo Details
2.5.2 Terumo Major Business
2.5.3 Terumo Infectious Disease Point of Care Diagnostics Product and Solutions
2.5.4 Terumo Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Terumo Recent Developments and Future Plans
2.6 BioMerieux
2.6.1 BioMerieux Details
2.6.2 BioMerieux Major Business
2.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Product and Solutions
2.6.4 BioMerieux Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 BioMerieux Recent Developments and Future Plans
2.7 Diasorin
2.7.1 Diasorin Details
2.7.2 Diasorin Major Business
2.7.3 Diasorin Infectious Disease Point of Care Diagnostics Product and Solutions
2.7.4 Diasorin Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Diasorin Recent Developments and Future Plans
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Infectious Disease Point of Care Diagnostics Product and Solutions
2.8.4 Roche Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Roche Recent Developments and Future Plans
2.9 Danaher Corporation
2.9.1 Danaher Corporation Details
2.9.2 Danaher Corporation Major Business
2.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Product and Solutions
2.9.4 Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Danaher Corporation Recent Developments and Future Plans
2.10 BD
2.10.1 BD Details
2.10.2 BD Major Business
2.10.3 BD Infectious Disease Point of Care Diagnostics Product and Solutions
2.10.4 BD Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 BD Recent Developments and Future Plans
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product and Solutions
2.11.4 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.12 Cavidi
2.12.1 Cavidi Details
2.12.2 Cavidi Major Business
2.12.3 Cavidi Infectious Disease Point of Care Diagnostics Product and Solutions
2.12.4 Cavidi Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Cavidi Recent Developments and Future Plans
2.13 Cepheid
2.13.1 Cepheid Details
2.13.2 Cepheid Major Business
2.13.3 Cepheid Infectious Disease Point of Care Diagnostics Product and Solutions
2.13.4 Cepheid Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Cepheid Recent Developments and Future Plans
2.14 Diaxonhit
2.14.1 Diaxonhit Details
2.14.2 Diaxonhit Major Business
2.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Product and Solutions
2.14.4 Diaxonhit Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Diaxonhit Recent Developments and Future Plans
2.15 Eiken Chemical
2.15.1 Eiken Chemical Details
2.15.2 Eiken Chemical Major Business
2.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Product and Solutions
2.15.4 Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Eiken Chemical Recent Developments and Future Plans
2.16 EMD Millipore
2.16.1 EMD Millipore Details
2.16.2 EMD Millipore Major Business
2.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Product and Solutions
2.16.4 EMD Millipore Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 EMD Millipore Recent Developments and Future Plans
2.17 Epitope Diagnostic
2.17.1 Epitope Diagnostic Details
2.17.2 Epitope Diagnostic Major Business
2.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product and Solutions
2.17.4 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Epitope Diagnostic Recent Developments and Future Plans
2.18 Euroimmun
2.18.1 Euroimmun Details
2.18.2 Euroimmun Major Business
2.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Product and Solutions
2.18.4 Euroimmun Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Euroimmun Recent Developments and Future Plans
2.19 Gold Standard Diagnostics
2.19.1 Gold Standard Diagnostics Details
2.19.2 Gold Standard Diagnostics Major Business
2.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product and Solutions
2.19.4 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Gold Standard Diagnostics Recent Developments and Future Plans
2.20 Hologic
2.20.1 Hologic Details
2.20.2 Hologic Major Business
2.20.3 Hologic Infectious Disease Point of Care Diagnostics Product and Solutions
2.20.4 Hologic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Hologic Recent Developments and Future Plans
2.21 Immunetics
2.21.1 Immunetics Details
2.21.2 Immunetics Major Business
2.21.3 Immunetics Infectious Disease Point of Care Diagnostics Product and Solutions
2.21.4 Immunetics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Immunetics Recent Developments and Future Plans
2.22 InBios International
2.22.1 InBios International Details
2.22.2 InBios International Major Business
2.22.3 InBios International Infectious Disease Point of Care Diagnostics Product and Solutions
2.22.4 InBios International Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 InBios International Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Infectious Disease Point of Care Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Infectious Disease Point of Care Diagnostics Players Market Share
3.2.2 Top 10 Infectious Disease Point of Care Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Infectious Disease Point of Care Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Infectious Disease Point of Care Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Infectious Disease Point of Care Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Infectious Disease Point of Care Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2026)
6.2 North America Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2026)
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Country
6.3.1 North America Infectious Disease Point of Care Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2026)
7.2 Europe Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2026)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Country
7.3.1 Europe Infectious Disease Point of Care Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region
8.3.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Region (2016-2026)
8.3.2 China Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2026)
9.2 South America Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2026)
9.3 South America Infectious Disease Point of Care Diagnostics Market Size by Country
9.3.1 South America Infectious Disease Point of Care Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country
10.3.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Infectious Disease Point of Care Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Infectious Disease Point of Care Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Infectious Disease Point of Care Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Infectious Disease Point of Care Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Infectious Disease Point of Care Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Infectious Disease Point of Care Diagnostics Product and Solutions
Table 9. Abbott Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Siemens Corporate Information, Head Office, and Major Competitors
Table 11. Siemens Major Business
Table 12. Siemens Infectious Disease Point of Care Diagnostics Product and Solutions
Table 13. Siemens Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 15. GE Healthcare Major Business
Table 16. GE Healthcare Infectious Disease Point of Care Diagnostics Product and Solutions
Table 17. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Accriva Corporate Information, Head Office, and Major Competitors
Table 19. Accriva Major Business
Table 20. Accriva Infectious Disease Point of Care Diagnostics Product and Solutions
Table 21. Accriva Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Terumo Corporate Information, Head Office, and Major Competitors
Table 23. Terumo Major Business
Table 24. Terumo Infectious Disease Point of Care Diagnostics Product and Solutions
Table 25. Terumo Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 27. BioMerieux Major Business
Table 28. BioMerieux Infectious Disease Point of Care Diagnostics Product and Solutions
Table 29. BioMerieux Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Diasorin Corporate Information, Head Office, and Major Competitors
Table 31. Diasorin Major Business
Table 32. Diasorin Infectious Disease Point of Care Diagnostics Product and Solutions
Table 33. Diasorin Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Roche Corporate Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche Infectious Disease Point of Care Diagnostics Product and Solutions
Table 37. Roche Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Danaher Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Danaher Corporation Major Business
Table 40. Danaher Corporation Infectious Disease Point of Care Diagnostics Product and Solutions
Table 41. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. BD Corporate Information, Head Office, and Major Competitors
Table 43. BD Major Business
Table 44. BD Infectious Disease Point of Care Diagnostics Product and Solutions
Table 45. BD Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 47. Bio-Rad Laboratories Major Business
Table 48. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product and Solutions
Table 49. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Cavidi Corporate Information, Head Office, and Major Competitors
Table 51. Cavidi Major Business
Table 52. Cavidi Infectious Disease Point of Care Diagnostics Product and Solutions
Table 53. Cavidi Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Cepheid Corporate Information, Head Office, and Major Competitors
Table 55. Cepheid Major Business
Table 56. Cepheid Infectious Disease Point of Care Diagnostics Product and Solutions
Table 57. Cepheid Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Diaxonhit Corporate Information, Head Office, and Major Competitors
Table 59. Diaxonhit Major Business
Table 60. Diaxonhit Infectious Disease Point of Care Diagnostics Product and Solutions
Table 61. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Eiken Chemical Corporate Information, Head Office, and Major Competitors
Table 63. Eiken Chemical Major Business
Table 64. Eiken Chemical Infectious Disease Point of Care Diagnostics Product and Solutions
Table 65. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. EMD Millipore Corporate Information, Head Office, and Major Competitors
Table 67. EMD Millipore Major Business
Table 68. EMD Millipore Infectious Disease Point of Care Diagnostics Product and Solutions
Table 69. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Epitope Diagnostic Corporate Information, Head Office, and Major Competitors
Table 71. Epitope Diagnostic Major Business
Table 72. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product and Solutions
Table 73. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Euroimmun Corporate Information, Head Office, and Major Competitors
Table 75. Euroimmun Major Business
Table 76. Euroimmun Infectious Disease Point of Care Diagnostics Product and Solutions
Table 77. Euroimmun Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Gold Standard Diagnostics Corporate Information, Head Office, and Major Competitors
Table 79. Gold Standard Diagnostics Major Business
Table 80. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product and Solutions
Table 81. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Hologic Corporate Information, Head Office, and Major Competitors
Table 83. Hologic Major Business
Table 84. Hologic Infectious Disease Point of Care Diagnostics Product and Solutions
Table 85. Hologic Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Immunetics Corporate Information, Head Office, and Major Competitors
Table 87. Immunetics Major Business
Table 88. Immunetics Infectious Disease Point of Care Diagnostics Product and Solutions
Table 89. Immunetics Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. InBios International Corporate Information, Head Office, and Major Competitors
Table 91. InBios International Major Business
Table 92. InBios International Infectious Disease Point of Care Diagnostics Product and Solutions
Table 93. InBios International Infectious Disease Point of Care Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Global Infectious Disease Point of Care Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 95. Global Infectious Disease Point of Care Diagnostics Revenue Share by Players (2019-2021)
Table 96. Breakdown of Infectious Disease Point of Care Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 97. Infectious Disease Point of Care Diagnostics Players Head Office, Products and Services Provided
Table 98. Infectious Disease Point of Care Diagnostics Mergers & Acquisitions in the Past Five Years
Table 99. Infectious Disease Point of Care Diagnostics New Entrants and Expansion Plans
Table 100. Global Infectious Disease Point of Care Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 101. Global Infectious Disease Point of Care Diagnostics Revenue Share by Type (2016-2021)
Table 102. Global Infectious Disease Point of Care Diagnostics Revenue Forecast by Type (2021-2026)
Table 103. Global Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2021)
Table 104. Global Infectious Disease Point of Care Diagnostics Revenue Forecast by Application (2021-2026)
Table 105. North America Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 106. North America Infectious Disease Point of Care Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 107. North America Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 108. North America Infectious Disease Point of Care Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 109. North America Infectious Disease Point of Care Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 110. North America Infectious Disease Point of Care Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 111. Europe Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 112. Europe Infectious Disease Point of Care Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 113. Europe Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 114. Europe Infectious Disease Point of Care Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 115. Europe Infectious Disease Point of Care Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 116. Europe Infectious Disease Point of Care Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 117. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 118. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 119. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 120. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 121. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 122. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 123. South America Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 124. South America Infectious Disease Point of Care Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 125. South America Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 126. South America Infectious Disease Point of Care Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 127. South America Infectious Disease Point of Care Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 128. South America Infectious Disease Point of Care Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 129. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 130. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 131. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 132. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 133. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 134. Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Infectious Disease Point of Care Diagnostics Picture
Figure 2. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type in 2020
Figure 3. Over-the-counter (OTC) Testing Kits
Figure 4. Prescription-based Testing Kits
Figure 5. Infectious Disease Point of Care Diagnostics Revenue Market Share by Application in 2020
Figure 6. Bacterial Infections Picture
Figure 7. Fungal Infection Picture
Figure 8. Virus Infection Picture
Figure 9. Cardiovascular Infection Picture
Figure 10. Gastrointestinal Infection Picture
Figure 11. Sexually Transmitted Disease (STD) Infection Picture
Figure 12. Central Nervous System Infection Picture
Figure 13. Other Picture
Figure 14. Global Infectious Disease Point of Care Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Infectious Disease Point of Care Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2016-2026)
Figure 17. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Region in 2020
Figure 18. North America Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Infectious Disease Point of Care Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Infectious Disease Point of Care Diagnostics Market Drivers
Figure 24. Infectious Disease Point of Care Diagnostics Market Restraints
Figure 25. Infectious Disease Point of Care Diagnostics Market Trends
Figure 26. Abbott Recent Developments and Future Plans
Figure 27. Siemens Recent Developments and Future Plans
Figure 28. GE Healthcare Recent Developments and Future Plans
Figure 29. Accriva Recent Developments and Future Plans
Figure 30. Terumo Recent Developments and Future Plans
Figure 31. BioMerieux Recent Developments and Future Plans
Figure 32. Diasorin Recent Developments and Future Plans
Figure 33. Roche Recent Developments and Future Plans
Figure 34. Danaher Corporation Recent Developments and Future Plans
Figure 35. BD Recent Developments and Future Plans
Figure 36. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 37. Cavidi Recent Developments and Future Plans
Figure 38. Cepheid Recent Developments and Future Plans
Figure 39. Diaxonhit Recent Developments and Future Plans
Figure 40. Eiken Chemical Recent Developments and Future Plans
Figure 41. EMD Millipore Recent Developments and Future Plans
Figure 42. Epitope Diagnostic Recent Developments and Future Plans
Figure 43. Euroimmun Recent Developments and Future Plans
Figure 44. Gold Standard Diagnostics Recent Developments and Future Plans
Figure 45. Hologic Recent Developments and Future Plans
Figure 46. Immunetics Recent Developments and Future Plans
Figure 47. InBios International Recent Developments and Future Plans
Figure 48. Global Infectious Disease Point of Care Diagnostics Revenue Share by Players in 2020
Figure 49. Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 50. Global Top 3 Players Infectious Disease Point of Care Diagnostics Revenue Market Share in 2020
Figure 51. Global Top 10 Players Infectious Disease Point of Care Diagnostics Revenue Market Share in 2020
Figure 52. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 53. Global Infectious Disease Point of Care Diagnostics Revenue Share by Type in 2020
Figure 54. Global Infectious Disease Point of Care Diagnostics Market Share Forecast by Type (2021-2026)
Figure 55. Global Infectious Disease Point of Care Diagnostics Revenue Share by Application in 2020
Figure 56. Global Infectious Disease Point of Care Diagnostics Market Share Forecast by Application (2021-2026)
Figure 57. North America Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2016-2026)
Figure 58. North America Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2016-2026)
Figure 59. North America Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2016-2026)
Figure 60. United States Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Canada Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Mexico Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Europe Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2016-2026)
Figure 64. Europe Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2016-2026)
Figure 65. Europe Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2016-2026)
Figure 66. Germany Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. France Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. United Kingdom Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Russia Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Italy Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2016-2026)
Figure 72. Asia-Pacific Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2016-2026)
Figure 73. Asia-Pacific Infectious Disease Point of Care Diagnostics Revenue Market Share by Region (2016-2026)
Figure 74. China Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Japan Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Korea Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. India Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Southeast Asia Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Australia Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South America Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2016-2026)
Figure 81. South America Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2016-2026)
Figure 82. South America Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2016-2026)
Figure 83. Brazil Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Argentina Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Middle East and Africa Infectious Disease Point of Care Diagnostics Sales Market Share by Type (2016-2026)
Figure 86. Middle East and Africa Infectious Disease Point of Care Diagnostics Sales Market Share by Application (2016-2026)
Figure 87. Middle East and Africa Infectious Disease Point of Care Diagnostics Revenue Market Share by Country (2016-2026)
Figure 88. Turkey Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. Saudi Arabia Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. UAE Infectious Disease Point of Care Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 91. Methodology
Figure 92. Research Process and Data Source
世界のポイントオブケア感染症診断・検査市場 2021：企業別、地域別、種類・用途別 The Point-of-Care Infectious Disease Diagnostics & Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…- 世界のポイントオブケア感染症市場 2021：企業別、地域別、種類・用途別 The Point of Care Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のB型肝炎感染症検査市場 2021：企業別、地域別、種類・用途別 The Hepatitis B Infectious Disease Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 獣医感染症診断の世界市場 2019年版：種類別（免疫診断、分子診断、その他の技術）、用途別（ラボ、病院、クリニック、その他） Scope of the Report: The global Veterinary Infectious Disease Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espe…
- ポイントオブケア（POC）分子診断の世界市場… Scope of the Report: The global Point-of-Care Molecular Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…